Ming Shi
17PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Dec 08, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.Zefeng Du, Zhicheng Lai, Yexing Huang
|Dec 17, 2024
Single-Nucleus and Spatial Transcriptome Profiling Delineates the Multicellular Ecosystem in Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.YeXing Huang, ZeFeng Du, ZhiCheng Lai
|Jul 16, 2024
UBA2 SUMOylates NQO1 and promotes the proliferation of hepatocellular carcinoma by modulating the MAPK pathway.Hailong Chen, Huifang Li, Minke He
|Oct 11, 2023
Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC).MinKe He, YeXing Huang, ZeFeng Du
|Oct 31, 2022
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.Zhicheng Lai, Yexing Huang, Dongsheng Wen
|Sep 13, 2022
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma.Miran Kim, Kam Man Hui, Ming Shi
Pageof 3
